Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Montreal Shantou Food Co., Ltd
Montreal Shantou Food Co., Ltd was founded in 1996, and specializing in producing and selling gummy candy, functional Gummy Candy, sugar free gummy candy and puffed food . We sticks to the principle of integrity & efficiency, take the interests of customers in the first place, constantly improve the product quality, strives to improve the quality and content of service, and has been advocating the development of our enterprise [ CREATE MORE VALUE TO CUSTOMER" the spirit of service. Over the years Montreal with stable product quality, excellent talents, qualified management for domestic and foreign customers to provide quality service, enjoy a good reputation in the food industry.
In order to provide customers with more quality products and services, Montreal constantly introduce advanced automatic equipment, develop and improve product formula, promote comprehensive service ability. At present, we have obtained professional certification of BRC, ISO22000, HACCP and HALAL. We keep struggling and provide the stable product quality, create more value.
Montreal Shantou Food Co., Ltd
Montreal Shantou Food Co., Ltd was founded in 1996, and specializing in producing and selling gummy candy, functional Gummy Candy, sugar free gummy candy and puffed food . We sticks to the principle of integrity & efficiency, take the interests of customers in the first place, constantly improve the product quality, strives to improve the quality and content of service, and has been advocating the development of our enterprise [ CREATE MORE VALUE TO CUSTOMER" the spirit of service. Over the years Montreal with stable product quality, excellent talents, qualified management for domestic and foreign customers to provide quality service, enjoy a good reputation in the food industry.
In order to provide customers with more quality products and services, Montreal constantly introduce advanced automatic equipment, develop and improve product formula, promote comprehensive service ability. At present, we have obtained professional certification of BRC, ISO22000, HACCP and HALAL. We keep struggling and provide the stable product quality, create more value.
Zhejiang Xianju Pharmaceutical Co., Ltd.
Zhejiang Xianju Pharmaceutical Co., Ltd. (stock code: 002332) was formerly the Xianju Pharmaceutical Factory. It was founded in 1972. The company has fulfilled the corporate mission of "your health and happiness, my sincerity and responsibility" to "become the whole world. The top ten steroid drug suppliers have become popular among customers and employees. "For the development vision, they focus on the field of steroid hormones. The company's total share capital is RMB 989.204866 million, and currently has more than 3,600 employees. The company is a key high-tech enterprise in the National Torch Program, and has a Zhejiang Steroid Drug Engineering Technology Research Center and a national postdoctoral workstation. Ranked 67th on the top 100 Chinese pharmaceutical industry enterprises in 2020. The company has unique products and adheres to the integrated business model of raw materials and preparations. Its main business is the development, production and sales of steroidal raw materials and preparations. Product research and development closely focuses on the four major therapeutic areas (gynecology, anesthesiology, respiratory and dermatology). The company has established long-term cooperative relationships with more than 20 well-known domestic scientific research institutes (schools) including the Shanghai Institute of Organics of the Chinese Academy of Sciences, Zhejiang University, and China Pharmaceutical University, recruited senior scientific research talents, and gradually connected with international new drug development. The company has initially formed a technical architecture system with professional foreign R&D institutions as the source, Hangzhou and Xianju Research Institutes as the digestion and acceptance, and Xianju Base as the implementation. The company's subsidiaries include 20 wholly-owned and controlled subsidiaries including Taizhou Xianju Pharmaceutical Co., Ltd. It has three core manufacturing platforms in China: Xianju Yangfu Raw Materials Production Zone, Xianju Yangfu Preparation Production Zone, and Linhai South Sichuan Production Zone. It has two standardized Raw Materials Factory abroad, mainly based on its Italian subsidiary NewChem. Xianju Pharmaceutical advocates real culture, win-win culture and innovative culture, and upholds the core corporate values of "integrity, hard work, openness, learning, responsibility, and win-win". The company adheres to the strategic concept of achieving win-win results in customers, enterprises, employees, society, etc., and advocates the value concept that personal value is reflected in the process of realizing corporate value and social value. In the future development process, the company will continue to improve the management level of the enterprise, continuously develop high-tech products, give full play to the scale effect, promote the high-quality development of the enterprise, and contribute to the cause of human health.
Zhejiang Xianju Pharmaceutical Co., Ltd.
Zhejiang Xianju Pharmaceutical Co., Ltd. (stock code: 002332) was formerly the Xianju Pharmaceutical Factory. It was founded in 1972. The company has fulfilled the corporate mission of "your health and happiness, my sincerity and responsibility" to "become the whole world. The top ten steroid drug suppliers have become popular among customers and employees. "For the development vision, they focus on the field of steroid hormones. The company's total share capital is RMB 989.204866 million, and currently has more than 3,600 employees. The company is a key high-tech enterprise in the National Torch Program, and has a Zhejiang Steroid Drug Engineering Technology Research Center and a national postdoctoral workstation. Ranked 67th on the top 100 Chinese pharmaceutical industry enterprises in 2020. The company has unique products and adheres to the integrated business model of raw materials and preparations. Its main business is the development, production and sales of steroidal raw materials and preparations. Product research and development closely focuses on the four major therapeutic areas (gynecology, anesthesiology, respiratory and dermatology). The company has established long-term cooperative relationships with more than 20 well-known domestic scientific research institutes (schools) including the Shanghai Institute of Organics of the Chinese Academy of Sciences, Zhejiang University, and China Pharmaceutical University, recruited senior scientific research talents, and gradually connected with international new drug development. The company has initially formed a technical architecture system with professional foreign R&D institutions as the source, Hangzhou and Xianju Research Institutes as the digestion and acceptance, and Xianju Base as the implementation. The company's subsidiaries include 20 wholly-owned and controlled subsidiaries including Taizhou Xianju Pharmaceutical Co., Ltd. It has three core manufacturing platforms in China: Xianju Yangfu Raw Materials Production Zone, Xianju Yangfu Preparation Production Zone, and Linhai South Sichuan Production Zone. It has two standardized Raw Materials Factory abroad, mainly based on its Italian subsidiary NewChem. Xianju Pharmaceutical advocates real culture, win-win culture and innovative culture, and upholds the core corporate values of "integrity, hard work, openness, learning, responsibility, and win-win". The company adheres to the strategic concept of achieving win-win results in customers, enterprises, employees, society, etc., and advocates the value concept that personal value is reflected in the process of realizing corporate value and social value. In the future development process, the company will continue to improve the management level of the enterprise, continuously develop high-tech products, give full play to the scale effect, promote the high-quality development of the enterprise, and contribute to the cause of human health.
Sino-American Tianjin SmithKline Pharmaceuticals Co., Ltd.
Xinkontech is a cold medicine brand under Sino-US SK. Specific products include: XinkangTeck Red Pack (ambroxolamine Tablets (II), XinkangTeck Blue Pack (compound pseudoephedrine hydrochloride sustained-release capsule), XinkangTeck Cough Medicine (ambroxol hydrochloride sustained-release capsule) and XinkangTeck Blue Pack (compound pseudoephedrine hydrochloride sustained-release capsule) and XinkangTeck Contec ventilation nose patch. Sino-US Tianjin Shike Pharmaceutical Co., Ltd. is a company jointly invested and established by GSK and the large domestic pharmaceutical factories Tianjin Sino-Singapore Pharmaceutical Group Co., Ltd. and Tianjin Pharmaceutical Group Co., Ltd. As one of the earliest foreign joint venture pharmaceutical factories established in China, Sino-US SKI took root in China as early as 1987.
Sino-American Tianjin SmithKline Pharmaceuticals Co., Ltd.
Xinkontech is a cold medicine brand under Sino-US SK. Specific products include: XinkangTeck Red Pack (ambroxolamine Tablets (II), XinkangTeck Blue Pack (compound pseudoephedrine hydrochloride sustained-release capsule), XinkangTeck Cough Medicine (ambroxol hydrochloride sustained-release capsule) and XinkangTeck Blue Pack (compound pseudoephedrine hydrochloride sustained-release capsule) and XinkangTeck Contec ventilation nose patch. Sino-US Tianjin Shike Pharmaceutical Co., Ltd. is a company jointly invested and established by GSK and the large domestic pharmaceutical factories Tianjin Sino-Singapore Pharmaceutical Group Co., Ltd. and Tianjin Pharmaceutical Group Co., Ltd. As one of the earliest foreign joint venture pharmaceutical factories established in China, Sino-US SKI took root in China as early as 1987.
Kenvue (pronounced ken·view) is inspired by two powerful concepts: "ken" comes from the Scottish dialect, meaning "knowledge" and "vue" means "vision". With extensive knowledge and insight into consumer needs, Kenvue will bring more meaningful personal health solutions to consumers around the world. "Loyalty to science" is Kenvue 's core proposition for protecting daily health and perpetuity. Kenvue has been seeking innovative solutions that meet people’s daily health needs and is working hard to bring them to consumers. Kenvue 's management team is like Kenvue 's consumers, with a diverse background that brings Kenvue rich experience and a diverse perspective. Kenvue 's purpose is very clear, because Kenvue firmly believes that the meaning of protecting daily health is not only health itself, but also empowering people to live a better life. We hope to convey this power to consumers and let people feel the beauty of this world with energy. Even in the face of difficulties and obstacles, we still insist on choosing the right path. Whether in ordinary daily life or at important and critical moments, Kenvue 's work is crucial to consumers, employees, and society, and will have a profound impact on generations. This huge responsibility means that we must always keep our integrity and quality in mind, and guide every decision and every step of our actions. Only when we practice people-oriented can our business continue to grow. Kenvue 's success stems from the people we serve. Only when Kenvue cares for everyone with all his heart can he create good health solutions. Kenvue works together to create an inclusive environment where everyone can unlock their full potential. Through close cooperation, we can build excellent external competitiveness. Only when our connections become stronger can the company and brand become stronger. From practice to products, Kenvue continues to learn, test, collaborate and optimize, bringing practical solutions to the community, family and everyone quickly. With leading science and technology, Kenvue educates and empowers the public to benefit from our products when they need it. Kenvue has won everyone's trust in the past century and will also be committed to continuing this trust every day in the future. Kenvue listens and addresses unmet needs. From the perspective of patients and consumers, Kenvue continues to make breakthroughs in protecting daily health, and with courage and belief, he promotes the implementation of ideas into reality. Kenvue boldly pursues more innovative ways of working, actively explores the possibility of improving life, creates new product categories, and achieves self-transcendence time and time again. From the first bathing of a newborn baby to pampering the skin or ease pain, Kenvue ’s products are always committed to protecting people’s daily health in a scientific and reliable way.
Kenvue (pronounced ken·view) is inspired by two powerful concepts: "ken" comes from the Scottish dialect, meaning "knowledge" and "vue" means "vision". With extensive knowledge and insight into consumer needs, Kenvue will bring more meaningful personal health solutions to consumers around the world. "Loyalty to science" is Kenvue 's core proposition for protecting daily health and perpetuity. Kenvue has been seeking innovative solutions that meet people’s daily health needs and is working hard to bring them to consumers. Kenvue 's management team is like Kenvue 's consumers, with a diverse background that brings Kenvue rich experience and a diverse perspective. Kenvue 's purpose is very clear, because Kenvue firmly believes that the meaning of protecting daily health is not only health itself, but also empowering people to live a better life. We hope to convey this power to consumers and let people feel the beauty of this world with energy. Even in the face of difficulties and obstacles, we still insist on choosing the right path. Whether in ordinary daily life or at important and critical moments, Kenvue 's work is crucial to consumers, employees, and society, and will have a profound impact on generations. This huge responsibility means that we must always keep our integrity and quality in mind, and guide every decision and every step of our actions. Only when we practice people-oriented can our business continue to grow. Kenvue 's success stems from the people we serve. Only when Kenvue cares for everyone with all his heart can he create good health solutions. Kenvue works together to create an inclusive environment where everyone can unlock their full potential. Through close cooperation, we can build excellent external competitiveness. Only when our connections become stronger can the company and brand become stronger. From practice to products, Kenvue continues to learn, test, collaborate and optimize, bringing practical solutions to the community, family and everyone quickly. With leading science and technology, Kenvue educates and empowers the public to benefit from our products when they need it. Kenvue has won everyone's trust in the past century and will also be committed to continuing this trust every day in the future. Kenvue listens and addresses unmet needs. From the perspective of patients and consumers, Kenvue continues to make breakthroughs in protecting daily health, and with courage and belief, he promotes the implementation of ideas into reality. Kenvue boldly pursues more innovative ways of working, actively explores the possibility of improving life, creates new product categories, and achieves self-transcendence time and time again. From the first bathing of a newborn baby to pampering the skin or ease pain, Kenvue ’s products are always committed to protecting people’s daily health in a scientific and reliable way.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd. (formerly Hangzhou Minsheng Pharmaceutical Factory) was founded in 1926 and is an early Western medicine factory and injection manufacturer in China. In 2000, it was reorganized into a private enterprise and was rated as a "time-old Chinese brand" enterprise by the Ministry of Commerce in 2006. For more than 90 years, Minsheng Pharmaceutical has been focusing on the Western pharmaceutical industry, witnessing the history of China's entire Western pharmaceutical pharmaceutical industry. The overall investment of Minsheng Factory exceeds 1.2 billion yuan, covering an area of 114,000 square meters and a construction area of 120,000 square meters. The factory area includes various production plants and other auxiliary facilities such as injections, infusions, tablets, capsules, ophthalmic drugs, external medicines, and other auxiliary facilities. All production lines comply with the new version of GMP verification. The company currently has 26 patents, a provincial technology center, a provincial R&D center, and a provincial enterprise research institute. It has successively won the National High-tech Enterprise, Zhejiang Province AAA-level "Contract-abiding and Credit-oriented" enterprise, and Hangzhou City Social Responsibility Construction AA Honorary titles such as grade enterprises. At this stage, Minsheng Pharmaceutical is committed to four major production lines: product line in the field of liver disease, product line in the field of anesthesia and analgesia, product line in the field of chronic diseases, product line in the field of specialized fields mainly in eye drops, ointments and blood tumors, providing people with health. It guarantees and implements the corporate purpose of "developing enterprises, winning cooperation, contributing to society, and benefiting employees".
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd. (formerly Hangzhou Minsheng Pharmaceutical Factory) was founded in 1926 and is an early Western medicine factory and injection manufacturer in China. In 2000, it was reorganized into a private enterprise and was rated as a "time-old Chinese brand" enterprise by the Ministry of Commerce in 2006. For more than 90 years, Minsheng Pharmaceutical has been focusing on the Western pharmaceutical industry, witnessing the history of China's entire Western pharmaceutical pharmaceutical industry. The overall investment of Minsheng Factory exceeds 1.2 billion yuan, covering an area of 114,000 square meters and a construction area of 120,000 square meters. The factory area includes various production plants and other auxiliary facilities such as injections, infusions, tablets, capsules, ophthalmic drugs, external medicines, and other auxiliary facilities. All production lines comply with the new version of GMP verification. The company currently has 26 patents, a provincial technology center, a provincial R&D center, and a provincial enterprise research institute. It has successively won the National High-tech Enterprise, Zhejiang Province AAA-level "Contract-abiding and Credit-oriented" enterprise, and Hangzhou City Social Responsibility Construction AA Honorary titles such as grade enterprises. At this stage, Minsheng Pharmaceutical is committed to four major production lines: product line in the field of liver disease, product line in the field of anesthesia and analgesia, product line in the field of chronic diseases, product line in the field of specialized fields mainly in eye drops, ointments and blood tumors, providing people with health. It guarantees and implements the corporate purpose of "developing enterprises, winning cooperation, contributing to society, and benefiting employees".
Shandong Jingwei Pharmaceutical Co., Ltd.
Shandong Jingwei Pharmaceutical Co., Ltd. is located in Tai'an National High-tech Zone at the foot of Mount Tai. Its main products are inhaled medicines in the respiratory field and in the mental and neurological field. The company has launched several first-generation drugs and products in China, and its main products maintain a high market share. Products are exported to more than 70 countries including the United States, Australia, New Zealand, etc. The company has successively formed strategic partners with international pharmaceutical companies such as Xian Janssen, kenvue, and Bayer, and has become the preferred partner for foreign pharmaceutical companies' CMO and CDMO business in China. The company adheres to innovation-driven and synergistics, focusing on high-difficulty inhalation preparations in the respiratory field and long-acting microsphere preparations in the central nervous field, deeply engaged in the subdivision of advanced technology of drug research and development, and has laid out the construction of "preparation + raw materials + key intermediates" integration. Advantages of value chains. The company has a R&D team of more than 300 people, and has R&D branches in Jinan, Beijing and Shanghai. The company adheres to the mission of "innovating for human health" and is committed to building an international pharmaceutical company with outstanding innovation capabilities.
Shandong Jingwei Pharmaceutical Co., Ltd.
Shandong Jingwei Pharmaceutical Co., Ltd. is located in Tai'an National High-tech Zone at the foot of Mount Tai. Its main products are inhaled medicines in the respiratory field and in the mental and neurological field. The company has launched several first-generation drugs and products in China, and its main products maintain a high market share. Products are exported to more than 70 countries including the United States, Australia, New Zealand, etc. The company has successively formed strategic partners with international pharmaceutical companies such as Xian Janssen, kenvue, and Bayer, and has become the preferred partner for foreign pharmaceutical companies' CMO and CDMO business in China. The company adheres to innovation-driven and synergistics, focusing on high-difficulty inhalation preparations in the respiratory field and long-acting microsphere preparations in the central nervous field, deeply engaged in the subdivision of advanced technology of drug research and development, and has laid out the construction of "preparation + raw materials + key intermediates" integration. Advantages of value chains. The company has a R&D team of more than 300 people, and has R&D branches in Jinan, Beijing and Shanghai. The company adheres to the mission of "innovating for human health" and is committed to building an international pharmaceutical company with outstanding innovation capabilities.
Sino-American Tianjin SmithKline Pharmaceuticals Co., Ltd.
FLIXONASE® nasal spray is trusted and a medicine that you trust. Can be purchased at major pharmacies without a doctor's prescription. Suitable for the prevention and treatment of seasonal allergic rhinitis (including dead grass fever) and perennial allergic rhinitis. Fushuliang Nasal Spray, the effect of using the medicine once a day can last for 24 hours, helping you effectively relieve nasal congestion, nasal itching, runny nose, sneezing, and allergic rhinitis discomfort. Fu Shuliang is affiliated to GlaxoSmithKline and is currently sold in many countries and regions around the world. GlaxoSmithKline is a research and development-based supplier of medicines and health products. It was formed by the merger of GlaxoWicken and SKP in 2000. It is in the fight against infection, central nervous system, respiratory and gastrointestinal tract, It has a high reputation and reputation in medical fields such as metabolism.
Sino-American Tianjin SmithKline Pharmaceuticals Co., Ltd.
FLIXONASE® nasal spray is trusted and a medicine that you trust. Can be purchased at major pharmacies without a doctor's prescription. Suitable for the prevention and treatment of seasonal allergic rhinitis (including dead grass fever) and perennial allergic rhinitis. Fushuliang Nasal Spray, the effect of using the medicine once a day can last for 24 hours, helping you effectively relieve nasal congestion, nasal itching, runny nose, sneezing, and allergic rhinitis discomfort. Fu Shuliang is affiliated to GlaxoSmithKline and is currently sold in many countries and regions around the world. GlaxoSmithKline is a research and development-based supplier of medicines and health products. It was formed by the merger of GlaxoWicken and SKP in 2000. It is in the fight against infection, central nervous system, respiratory and gastrointestinal tract, It has a high reputation and reputation in medical fields such as metabolism.
Merck Sharp & Dohme (China) Investment Co., Ltd.
For 130 years, Merck has always followed the mission of saving lives and improving lives, committed to enhancing life and bringing medicines and vaccines to overcome difficult diseases around the world. Through far-reaching policies, programs and partnerships, Merck fulfills its commitment to improve access to health care for patients and the general public. Today, Merck continues to be at the forefront of R&D, promoting its prevention and treatment of diseases that threaten human and animal health around the world—including cancer, infectious diseases such as HIV and Ebola viruses and emerging animal diseases. Merck focuses on scientific research and innovation, exploration, development, and provides drugs and vaccines that benefit millions of people around the world. Vaccines are one of the most effective areas of public health - Merck has been constantly exploring, developing and providing vaccines for disease prevention over the course of a century. Merck has played an important role in exploring, developing innovative drugs and vaccines for the treatment and prevention of infectious diseases. Merck is committed to finding solutions to severe chronic diseases such as cardiovascular disease and diabetes. Merck Animal Health is driven by research and develop, produce and sell a wide range of veterinary medicines and services. Whether it is R&D, manufacturing or sales, Merck's animal health business is a leader in the global market. Products cover the prevention, treatment and control of diseases in poultry and pets. China is a crucial part of Merck's global growth strategy. Merck China is headquartered in Shanghai, with a R&D center in Beijing and a factory in Hangzhou, realizing the integration of R&D, manufacturing and commercial operations. Merck is wholeheartedly providing high-quality innovative drugs, vaccines and services to the Chinese public to benefit Chinese society.
Merck Sharp & Dohme (China) Investment Co., Ltd.
For 130 years, Merck has always followed the mission of saving lives and improving lives, committed to enhancing life and bringing medicines and vaccines to overcome difficult diseases around the world. Through far-reaching policies, programs and partnerships, Merck fulfills its commitment to improve access to health care for patients and the general public. Today, Merck continues to be at the forefront of R&D, promoting its prevention and treatment of diseases that threaten human and animal health around the world—including cancer, infectious diseases such as HIV and Ebola viruses and emerging animal diseases. Merck focuses on scientific research and innovation, exploration, development, and provides drugs and vaccines that benefit millions of people around the world. Vaccines are one of the most effective areas of public health - Merck has been constantly exploring, developing and providing vaccines for disease prevention over the course of a century. Merck has played an important role in exploring, developing innovative drugs and vaccines for the treatment and prevention of infectious diseases. Merck is committed to finding solutions to severe chronic diseases such as cardiovascular disease and diabetes. Merck Animal Health is driven by research and develop, produce and sell a wide range of veterinary medicines and services. Whether it is R&D, manufacturing or sales, Merck's animal health business is a leader in the global market. Products cover the prevention, treatment and control of diseases in poultry and pets. China is a crucial part of Merck's global growth strategy. Merck China is headquartered in Shanghai, with a R&D center in Beijing and a factory in Hangzhou, realizing the integration of R&D, manufacturing and commercial operations. Merck is wholeheartedly providing high-quality innovative drugs, vaccines and services to the Chinese public to benefit Chinese society.
Shenzhen Xingyin Pharmaceutical Co., Ltd.
Since its establishment in 1994, Shenzhen Xingyin Pharmaceutical Co., Ltd. (hereinafter referred to as "Xingyin Pharmaceutical") has focused on the development of the pharmaceutical industry and has gradually grown into a comprehensive pharmaceutical group enterprise integrating science, industry and trade. Over the past 20 years, Xingyin Pharmaceutical has established 10 pharmaceutical subsidiaries in Shenzhen, Nanjing, Hubei and other places, and has established prescriptions nationwide: 4 major regions, 8 provinces and regions, and 67 offices; retail: 5 A professional academic marketing team has been built in the region and 25 sales areas. So far, Xingyin Pharmaceutical has a complete pharmaceutical industry chain and is an excellent pharmaceutical company with strong independent innovation capabilities and high sustainable development capabilities in China. Since its establishment, Xingyin Pharmaceutical has insisted on contributing high-quality products, serving the people and benefiting the society. In the early 1990s, Xingyin Pharmaceutical introduced the German pure plant medicine Maizhiling tablets. Its products independently developed and produced Xingrui, Gegen Decoction, compound codeine phosphate oral solution and other products, which were widely used in major domestic hospitals. The clinical department has received unanimous praise from clinical experts and the majority of patients. In 2002, Xingyin Pharmaceutical built a large modern pharmaceutical production base covering an area of 250 acres in Lishui Economic Development Zone, Jiangsu Province, and was engaged in the production of various dosage form drugs. In order to achieve continuous innovation in drug research and development and production technology, in 2010, Xingyin Pharmaceutical Investment Holds Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. In February of the same year, Jianyuan Pharmaceutical officially established a R&D laboratory in the biological incubator of Shenzhen High-tech Zone and started the construction of Nanjing Lishui Raw Materials Production Center. In 2013, Jianyuan Pharmaceutical settled in the "Shenzhen National Bioindustry Base" in Pingshan New District and built three new drug preparation production lines and a 5,000 square meter R&D center laboratory that meets the national new drug R&D standards. In 2015, Xingyin Investment Group signed a contract with 660 mu of land in the Xian'an Economic Development Zone, Hubei to build a new bio-raw drug production base, headquarters meeting, training, reception, information center and R&D center. After production, Hubei Jianxiang will be Become a large-scale production base for polypeptide raw materials in China and even Asia. At present, Xingyin Pharmaceutical has nearly 100 invention patents and product design patents, more than 30 new drugs of various types under development, and no less than 4 new biological agents have entered the approval sequence every year. As a high-tech enterprise, Xingyin Pharmaceutical makes great efforts in the field of pharmaceutical research and development every year, striving to accelerate the development of innovative drugs and become stronger and bigger in the pharmaceutical market.
Shenzhen Xingyin Pharmaceutical Co., Ltd.
Since its establishment in 1994, Shenzhen Xingyin Pharmaceutical Co., Ltd. (hereinafter referred to as "Xingyin Pharmaceutical") has focused on the development of the pharmaceutical industry and has gradually grown into a comprehensive pharmaceutical group enterprise integrating science, industry and trade. Over the past 20 years, Xingyin Pharmaceutical has established 10 pharmaceutical subsidiaries in Shenzhen, Nanjing, Hubei and other places, and has established prescriptions nationwide: 4 major regions, 8 provinces and regions, and 67 offices; retail: 5 A professional academic marketing team has been built in the region and 25 sales areas. So far, Xingyin Pharmaceutical has a complete pharmaceutical industry chain and is an excellent pharmaceutical company with strong independent innovation capabilities and high sustainable development capabilities in China. Since its establishment, Xingyin Pharmaceutical has insisted on contributing high-quality products, serving the people and benefiting the society. In the early 1990s, Xingyin Pharmaceutical introduced the German pure plant medicine Maizhiling tablets. Its products independently developed and produced Xingrui, Gegen Decoction, compound codeine phosphate oral solution and other products, which were widely used in major domestic hospitals. The clinical department has received unanimous praise from clinical experts and the majority of patients. In 2002, Xingyin Pharmaceutical built a large modern pharmaceutical production base covering an area of 250 acres in Lishui Economic Development Zone, Jiangsu Province, and was engaged in the production of various dosage form drugs. In order to achieve continuous innovation in drug research and development and production technology, in 2010, Xingyin Pharmaceutical Investment Holds Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. In February of the same year, Jianyuan Pharmaceutical officially established a R&D laboratory in the biological incubator of Shenzhen High-tech Zone and started the construction of Nanjing Lishui Raw Materials Production Center. In 2013, Jianyuan Pharmaceutical settled in the "Shenzhen National Bioindustry Base" in Pingshan New District and built three new drug preparation production lines and a 5,000 square meter R&D center laboratory that meets the national new drug R&D standards. In 2015, Xingyin Investment Group signed a contract with 660 mu of land in the Xian'an Economic Development Zone, Hubei to build a new bio-raw drug production base, headquarters meeting, training, reception, information center and R&D center. After production, Hubei Jianxiang will be Become a large-scale production base for polypeptide raw materials in China and even Asia. At present, Xingyin Pharmaceutical has nearly 100 invention patents and product design patents, more than 30 new drugs of various types under development, and no less than 4 new biological agents have entered the approval sequence every year. As a high-tech enterprise, Xingyin Pharmaceutical makes great efforts in the field of pharmaceutical research and development every year, striving to accelerate the development of innovative drugs and become stronger and bigger in the pharmaceutical market.
Nasacort is a corticosteroid nasal spray that helps reduce inflammation and relieve allergy symptoms.
Sanofi
Nasacort is a corticosteroid nasal spray that helps reduce inflammation and relieve allergy symptoms.
Beconase AQ is a corticosteroid nasal spray used to treat nasal symptoms of hay fever and other nasal allergies.
GlaxoSmithKline (GSK)
Beconase AQ is a corticosteroid nasal spray used to treat nasal symptoms of hay fever and other nasal allergies.
Afrin is a decongestant nasal spray that provides quick relief from nasal congestion due to colds, allergies, or sinusitis.
Bayer
Afrin is a decongestant nasal spray that provides quick relief from nasal congestion due to colds, allergies, or sinusitis.
Otrivin offers effervescent tablets for nasal decongestion, providing relief from cold and sinus symptoms.
GlaxoSmithKline plc
Otrivin offers effervescent tablets for nasal decongestion, providing relief from cold and sinus symptoms.
Dymista is a nasal spray brand that combines an antihistamine and a corticosteroid to provide relief from allergic rhinitis. It is known for its dual-action formula that reduces inflammation and allergy symptoms.
Meda Pharmaceuticals
Dymista is a nasal spray brand that combines an antihistamine and a corticosteroid to provide relief from allergic rhinitis. It is known for its dual-action formula that reduces inflammation and allergy symptoms.
Astepro is a nasal spray brand that provides fast relief from nasal allergy symptoms. It is known for its antihistamine-based formula that reduces congestion and sneezing.
Meda Pharmaceuticals
Astepro is a nasal spray brand that provides fast relief from nasal allergy symptoms. It is known for its antihistamine-based formula that reduces congestion and sneezing.
Rhinocort is a nasal spray brand that provides relief from hay fever and other nasal allergies. It is known for its corticosteroid-based formula that reduces inflammation.
AstraZeneca
Rhinocort is a nasal spray brand that provides relief from hay fever and other nasal allergies. It is known for its corticosteroid-based formula that reduces inflammation.
Nasonex is a prescription nasal spray used to treat nasal allergy symptoms, including congestion and sneezing. It is also effective for preventing seasonal allergies.
Merck & Co., Inc.
Nasonex is a prescription nasal spray used to treat nasal allergy symptoms, including congestion and sneezing. It is also effective for preventing seasonal allergies.
Flonase is a nasal spray brand that provides relief from seasonal and year-round allergies. It works by reducing inflammation in the nasal passages.
GlaxoSmithKline
Flonase is a nasal spray brand that provides relief from seasonal and year-round allergies. It works by reducing inflammation in the nasal passages.
Zyrtec is a leading antihistamine brand known for its effectiveness in treating allergies, including hay fever and hives. It offers both prescription and over-the-counter options.
Johnson & Johnson
Zyrtec is a leading antihistamine brand known for its effectiveness in treating allergies, including hay fever and hives. It offers both prescription and over-the-counter options.
